SCHEMBL2733313

SCHEMBL2733313

COc1cc(OC(C)(C)C)cc(OC)c1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 1/20 0.50
▸ CYP3A4 P08684 1/20 0.48
▸ MAPT P10636 1/20 0.48
▸ CA9 Q16790 1/20 0.48
▸ PTGS2 P35354 1/20 0.45
▸ CYP1A2 P05177 3/20 0.44
▸ CYP1A1 P04798 2/20 0.44
▸ CYP1B1 Q16678 2/20 0.44
▸ TUBB4A P04350 5/20 0.43
▸ TUBB P07437 5/20 0.43
▸ TUBA3C P0DPH7 5/20 0.43
▸ TUBA1B P68363 5/20 0.43
▸ TUBA4A P68366 5/20 0.43
▸ TUBB4B P68371 5/20 0.43
▸ TUBB3 Q13509 5/20 0.43
▸ TUBB2A Q13885 5/20 0.43
▸ TUBB8 Q3ZCM7 5/20 0.43
▸ TUBA3E Q6PEY2 5/20 0.43
▸ TUBA1A Q71U36 5/20 0.43
▸ TUBA1C Q9BQE3 5/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14805638 0.82 SRC (0.42) ACHECYP3A4MAPTCA9KDM4E
SCHEMBL2730880 0.80 PTGS2 (0.48) ACHECYP3A4MAPTCA9PTGS2
SCHEMBL17312044 0.78 CYP3A4 (0.45) ACHECYP3A4MAPTCA9PTGS2
SCHEMBL686849 0.78 CYP1A2 (0.64) ACHECYP3A4MAPTCA9PTGS2
SCHEMBL2734115 0.77 CA12 (0.34) ACHECYP3A4CA9CYP1A2CYP1A1
SCHEMBL14805871 0.76 CA2 (0.64) ACHECYP3A4MAPTCA9CYP1A2
SCHEMBL14075676 0.75 ALDH1A1 (0.61) CYP3A4CA9PTGS2CYP1A2CYP1A1
SCHEMBL16437141 0.75 CYP1A2 (0.36) CYP3A4CA9CYP1A2HTR2AHTR2C
SCHEMBL3818720 0.74 ALDH1A1 (0.39) ALDH1A1
SCHEMBL10462164 0.73 ALDH1A1 (0.32) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088805-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2012-01-03 — — US disclosed
US-20100331348-A1 TROPANE DERIVATIVES USEFUL AS PESTICIDES SYNGENTA CROP PROTECTION, INC. (US) 2010-12-30 — — US disclosed
US-20070213330-A1 Anticancer agents; antiproliferative agents METHYLGENE INC. (CA) 2007-09-13 — — US disclosed
US-7253204-B2 Antiproliferative agents METHYLGENE INC. (CA) 2007-08-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213330-A1 Anticancer agents; antiproliferative agents HDAC1, HDAC11, HDAC5 ACHE 3428/4885CYP3A4 4595/4885MAPT 3612/4885
US-20100331348-A1 TROPANE DERIVATIVES USEFUL AS PESTICIDES DDT, ACHE, TPM3 ACHE 2/4885CYP3A4 170/4885MAPT 2103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback